Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial

Authors:

Abstract
No abstract available
Funding Information
  • Meso Scale Diagnostics
  • GlaxoSmithKline
  • Astellas Pharma Canada
  • Biomedical Advanced Research and Development Authority
  • Sanofi Pasteur
  • F. Hoffmann-La Roche Ltd
  • bioMérieux
  • F. Hoffmann-La Roche

This publication has 24 references indexed in Scilit: